Data as of Nov 4, 2026.
BBC vs GNOM: Holdings Overlap & Returns
Over the year to Nov 4, 2026, BBC returned +45.9% to GNOM's +66.6%; 6% of their weight is in the same names.
askIQ about this page
askIQ about BBC and GNOMNet assets: $46m on Jul 31, 2026 for Virtus Biotech Clinical Trials ETF, and $104m on Oct 12, 2026 for Global X Genomics & Biotechnology ETF.
0% of BBC's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Jul 31, 2026.
21% of GNOM's weight is in S&P 500 companies and 79% is outside the index. Holdings as of Aug 31, 2026.
Pair scorecard
GNOM costs 0.15 points a year less; their one-year returns differ by 20.7 points.
| Measure | BBC | GNOM |
|---|---|---|
| Return | ||
| Total return, 1 year | +45.9% | +66.6% |
| Drawdown | ||
| Below its all-time high | 27.4%, high on Feb 8, 2021 | 36.2%, high on Feb 8, 2021 |
| Benchmark | ||
| What it tracks | Biotech | Genomics and gene editing |
| Cost and size | ||
| Expense ratio | 0.65% | 0.50% |
| Net assets, BBC as of Jul 31, 2026 and GNOM as of Oct 12, 2026 | $46m | $104m |
| Holdings | ||
| Holdings in common | 6% | |
What they share
By the books each fund has filed, BBC and GNOM hold 6% of their money in the same securities at the same weight. Holdings dated Jul 31, 2026 and Aug 31, 2026.
half
6% in common
Only in one fund ↓
Window by window
| Total return | ||
|---|---|---|
| Window | BBC | GNOM |
| 3 months | −14.8% | +24.5% |
| 6 months | −5.2% | +49.4% |
| 1 year | +45.9% | +66.6% |
| 3 years | +132.0% | +81.6% |
| Since launchNot the same days: BBC Dec 2014 · GNOM Apr 2019 | +72.8% | +16.0% |
Side by side
As of Nov 4, 2026. Source: ETFIQ.
6% of the two portfolios are the same securities at the same weight.
BBC
By weight, 0% of BBC's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 12% of the fund across 131 positions, as filed for Jul 31, 2026. Over the year to Nov 4, 2026 the fund returned +45.9% with distributions reinvested. It sits 27.4% below its all-time high of Feb 8, 2021.
GNOM
By weight, 21% of GNOM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 49% of the fund across 50 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +66.6% with distributions reinvested. It sits 36.2% below its all-time high of Feb 8, 2021.
Questions people ask
- Do BBC and GNOM hold the same stocks?
- By their latest filings, 6% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, BBC against GNOM, data as of Nov 4, 2026. https://etfiq.com/compare/themes/bbc-vs-gnom
ETFIQ. (Nov 4, 2026). BBC against GNOM. Retrieved from https://etfiq.com/compare/themes/bbc-vs-gnom
[BBC against GNOM (ETFIQ, Nov 4, 2026)](https://etfiq.com/compare/themes/bbc-vs-gnom)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.